Medications

New drug candidate developed to treat type 2 diabetes

A team of researchers from Helmholtz Munich, the German Center for Diabetes Research (DZD) and Novo Nordisk have developed a new hormone combination for the future treatment of type 2 diabetes. The scientists have combined ...

Neuroscience

Ketamine found to be unlikely to lead to addiction

A team of researchers at the University of Geneva has found that ketamine is unlikely to be addictive to people who use it for extended periods of time. In their paper published in the journal Nature, the group describes ...

Neuroscience

Making sense of socially enhanced aggression in the brains of mice

When male animals spend time around other males of the same species, subsequent aggressive behavior tends to be amplified—this type of priming is known as social instigation. However, the pathway in the brain that leads ...

page 4 from 25